Antral follicle count measured any day of the cycle and menstrual cycle length as reliable markers of ovarian reserve DOI Creative Commons
Sara Peralta,

F. Fàbregues,

Yasmina Barral

et al.

Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 15, 2024

Abstract Background Routine gynaecological screening should incorporate simple and easily available ovarian reserve markers to ensure optimal reproductive health counselling. The purpose of this study is evaluate whether antral follicle count measured randomly during the menstrual cycle (rAFC) length (MCL) can predict response in women undergoing assisted technology. Methods 122 with regular cycles their first vitro fertilization were included. Transvaginal ultrasound was performed, previous posterior menses’ dates, anti-Müllerian hormone (AMH) body mass index recorded. Visits scheduled: 52 patients screened follicular phase (7 early 2–4) 70 luteal phase. Poor defined < four oocytes retrieved or cancellation due impaired absent growth high as ≥ 15 oocytes. cumulative live birth rate (CLBR) per initiated IVF also analysed. Results 16 classified (13.1%), 79 (64.8%) normal 27 (22.1%) poor responders. 51 achieved at least one (CLBR = 41.8% started cycle). rAFC MCL presented a significant positive correlation total number retrieved. showed an excellent ability poor, hyper-response CLB: AUCROC 0.91 (95%CI 0.84–0.95); 0.83 0.76–0.89) 0.78 0.70–0.85) while only good predictor 0.75 0.66–0.82). Conclusion present demonstrates that low short are strongly associated response, being reliable reserve.

Language: Английский

A systematic review and meta-analysis of double trophectoderm biopsy and/or cryopreservation in PGT: balancing the need for a diagnosis against the risk of harm DOI
Letizia Li Piani, Pasquale Petrone,

Mariafrancesca Brutto

et al.

Human Reproduction Update, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 13, 2024

To prevent the transfer of embryos affected by monogenic conditions and/or chromosomal defects, preimplantation genetic testing (PGT) requires trophectoderm biopsy and cryopreservation. In 2-6% biopsies, diagnosis may be inconclusive due to DNA amplification failure or low-quality results. these cases, a round re-warming, re-biopsy, re-cryopreservation is required obtain diagnosis. other when IVF centre starts providing PGT patients develop an indication because multiple failures, miscarriages birth child after IVF, cryopreserved untested warmed, biopsied, then re-vitrified. However, it still unclear whether manipulations reduce reproductive outcomes PGT.

Language: Английский

Citations

3
P4 Reproductive Medicine: Prediction, Prevention, Personalization, and Participation in Infertility Care DOI Open Access
Danilo Cimadomo, Andrea Garolla, Amerigo Vitagliano

et al.

Journal of Clinical Medicine, Journal Year: 2024, Volume and Issue: 13(19), P. 5860 - 5860

Published: Oct. 1, 2024

Infertility affects approximately 10–15% of couples in their reproductive age, and its impact is escalating globally [...]

Language: Английский

Citations

2
The Mental Health Traumas of Infertility DOI
Julie Bindeman,

Roohollah Abbasi,

Preston C. Sacks

et al.

Obstetrics and Gynecology Clinics of North America, Journal Year: 2024, Volume and Issue: 52(1), P. 133 - 143

Published: Nov. 7, 2024

Language: Английский

Citations

2
Altered endometrial receptivity: back to the future again? DOI
Paul Pirtea, James P. Toner, Richard T. Scott

et al.

Fertility and Sterility, Journal Year: 2024, Volume and Issue: 122(3), P. 549 - 550

Published: May 8, 2024

Language: Английский

Citations

1
Updates in preimplantation genetic testing (PGT) DOI

Sarah Petch,

David C. Crosby

Best Practice & Research Clinical Obstetrics & Gynaecology, Journal Year: 2024, Volume and Issue: 96, P. 102526 - 102526

Published: June 19, 2024

Preimplantation genetic testing (PGT) involves taking a biopsy of an early embryo created through in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI). Genetic is performed on the biopsy, order to select which transfer. PGT began as experimental procedure 1990s, but now integral part assisted human reproduction (AHR). allows for selection can reduce risk transmission inherited disease and may chance implantation failure pregnancy loss. This rapidly evolving area, raises important ethical issues. review article aims give brief history PGT, overview current evidence along with highlighting exciting areas research advance this technology.

Language: Английский

Citations

1
Reply of the Authors: Altered endometrial receptivity: walking across the long path of precision medicine DOI
Patricia Díaz-Gimeno, Patricia Sebastián-León, António Pellicer

et al.

Fertility and Sterility, Journal Year: 2024, Volume and Issue: 122(3), P. 551 - 551

Published: June 19, 2024

Language: Английский

Citations

1
Reply of the authors: Unexplained recurrent implantation failure is rare! DOI
Paul Pirtea, Marcelle I. Cedars,

Kate Devine

et al.

Fertility and Sterility, Journal Year: 2024, Volume and Issue: 122(6), P. 1163 - 1164

Published: Aug. 14, 2024

Language: Английский

Citations

1
Reply. Recurrent implantation failure in patients undergoing euploid embryo transfers are unlikely to be caused by unmodifiable extra-embryonic factors DOI
Barış Ata, Pavan Gill, Danilo Cimadomo

et al.

Human Reproduction, Journal Year: 2024, Volume and Issue: 39(10), P. 2370 - 2370

Published: Aug. 22, 2024

Journal Article Reply. Recurrent implantation failure in patients undergoing euploid embryo transfers are unlikely to be caused by unmodifiable extra-embryonic factors Get access Baris Ata, Ata ART Fertility Clinics, Dubai, United Arab EmiratesDepartment of Obstetrics and Gynecology, Koç University School Medicine, Istanbul, Turkiye Search for other works this author on: Oxford Academic PubMed Google Scholar Pavan Gill, Gill IVIRMA Global Research Alliance, New Jersey, Basking Ridge, NJ, USA Danilo Cimadomo, Cimadomo Genera, Clinica Valle Giulia, Rome, Italy Filippo Maria Ubaldi, Ubaldi Juan A Garcia-Velasco, Garcia-Velasco Madrid, Spain Emre Seli USADepartment Obstetrics, Reproductive Sciences, Yale Haven, CT, Corrrespondence address. 140 Allen Road, NJ 07920, USA. E-mail: [email protected] https://orcid.org/0000-0001-7464-8203 Human Reproduction, deae185, https://doi.org/10.1093/humrep/deae185 Published: 22 August 2024

Language: Английский

Citations

1
Challenges ahead: catalyzing research for the 2% prevalence of repeated implantation failure DOI
Hossam Elzeiny

Human Reproduction, Journal Year: 2024, Volume and Issue: 39(10), P. 2368 - 2369

Published: Aug. 22, 2024

Journal Article Challenges ahead: catalyzing research for the 2% prevalence of repeated implantation failure Get access Hossam Elzeiny Melbourne IVF East Melbourne, AustraliaReproductive Services Unit, Royal Women's Hospital, Australia Correspondence address. Reproductive Australia. E-mail: [email protected] https://orcid.org/0000-0003-3003-3439 Search other works by this author on: Oxford Academic PubMed Google Scholar Human Reproduction, deae184, https://doi.org/10.1093/humrep/deae184 Published: 22 August 2024

Language: Английский

Citations

1
Biopsy vitrification: New tool for endometrial tissue cryopreservation for research applications DOI
Merli Saare, Monika Wróbel, Yanyu Jiang

et al.

Cryobiology, Journal Year: 2024, Volume and Issue: 117, P. 105161 - 105161

Published: Nov. 15, 2024

Language: Английский

Citations

1